Menu
Logo

Adverse events reporting | Prescribing informationPONVORY® ▼ (ponesimod) ( ▼ This product is under additional monitoring)

The PONVORY® Risk Minimisation Materials are available to provide further information, advice and support on PONVORY®.

Prescriber Checklist

A checklist for you the HCP to remember important points before, during and after treatment.


Pregnancy Reminder Card

A reminder card for patients that have been prescribed with Ponvory®.

Patient Caregiver Guide

A guide with important information to ensure safe and effective use of Ponvory®.

CAN'T FIND WHAT YOU'RE LOOKING FOR?

We would be happy to assist you.

DISCOVER the convenience and flexibility of PONVORY®
SEE overall rates of treatment emergent adverse events vs teriflunomide from OPTIMUM
FIND OUT more about how PONVORY® works

RMS=relapsing multiple sclerosis

  1. Ponvory Summary of Product Characteristics Available at: www.medicines.ie
CP-280405 - February 2022
© Janssen Sciences Ireland UC. This site is published by Janssen Sciences Ireland UC which is solely responsible for its content. It is intended for Irish healthcare professionals. Third party trademarks used herein are trademarks of their respective owners.
Cookie Settings
Logo